UniProt ID | CLUA1_HUMAN | |
---|---|---|
UniProt AC | Q96AJ1 | |
Protein Name | Clusterin-associated protein 1 | |
Gene Name | CLUAP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 413 | |
Subcellular Localization | Cell projection, cilium . Nucleus . | |
Protein Description | Required for cilia biogenesis. Appears to function within the multiple intraflagellar transport complex B (IFT-B). Key regulator of hedgehog signaling.. | |
Protein Sequence | MSFRDLRNFTEMMRALGYPRHISMENFRTPNFGLVSEVLLWLVKRYEPQTDIPPDVDTEQDRVFFIKAIAQFMATKAHIKLNTKKLYQADGYAVKELLKITSVLYNAMKTKGMEGSEIVEEDVNKFKFDLGSKIADLKAARQLASEITSKGASLYDLLGMEVELREMRTEAIARPLEINETEKVMRIAIKEILTQVQKTKDLLNNVASDEANLEAKIEKRKLELERNRKRLETLQSVRPCFMDEYEKTEEELQKQYDTYLEKFQNLTYLEQQLEDHHRMEQERFEEAKNTLCLIQNKLKEEEKRLLKSGSNDDSDIDIQEDDESDSELEERRLPKPQTAMEMLMQGRPGKRIVGTMQGGDSDDNEDSEESEIDMEDDDDEDDDLEDESISLSPTKPNRRVRKSEPLDESDNDF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSFRDLRNF ------CCHHHHHHH | 29.05 | 24719451 | |
34 (in isoform 2) | Ubiquitination | - | 3.16 | 21906983 | |
50 (in isoform 2) | Ubiquitination | - | 46.76 | 21906983 | |
80 | Ubiquitination | MATKAHIKLNTKKLY HHHHHHHHCCCCHHH | 26.31 | - | |
85 | Acetylation | HIKLNTKKLYQADGY HHHCCCCHHHCCCCH | 50.84 | 19816681 | |
85 | Ubiquitination | HIKLNTKKLYQADGY HHHCCCCHHHCCCCH | 50.84 | - | |
95 | Acetylation | QADGYAVKELLKITS CCCCHHHHHHHHHHH | 34.18 | 19816693 | |
95 | Ubiquitination | QADGYAVKELLKITS CCCCHHHHHHHHHHH | 34.18 | - | |
111 | Ubiquitination | LYNAMKTKGMEGSEI HHHHHHHCCCCCCHH | 51.22 | 21906983 | |
111 (in isoform 1) | Ubiquitination | - | 51.22 | 21906983 | |
116 | Phosphorylation | KTKGMEGSEIVEEDV HHCCCCCCHHHHHHH | 15.73 | 30622161 | |
125 | Ubiquitination | IVEEDVNKFKFDLGS HHHHHHHHHCCCCCH | 50.18 | - | |
133 (in isoform 1) | Ubiquitination | - | 39.86 | 21906983 | |
133 | Ubiquitination | FKFDLGSKIADLKAA HCCCCCHHHHHHHHH | 39.86 | 21906983 | |
138 | Ubiquitination | GSKIADLKAARQLAS CHHHHHHHHHHHHHH | 40.31 | - | |
165 | Dimethylation | LGMEVELREMRTEAI HCCEEEHHHHHHHHH | 23.35 | - | |
168 | Dimethylation | EVELREMRTEAIARP EEEHHHHHHHHHHCC | 25.35 | - | |
190 | Ubiquitination | KVMRIAIKEILTQVQ HHHHHHHHHHHHHHH | 29.67 | - | |
194 | Phosphorylation | IAIKEILTQVQKTKD HHHHHHHHHHHHHHH | 32.15 | - | |
198 | Ubiquitination | EILTQVQKTKDLLNN HHHHHHHHHHHHHHH | 59.70 | - | |
199 | Phosphorylation | ILTQVQKTKDLLNNV HHHHHHHHHHHHHHH | 16.82 | - | |
200 | Ubiquitination | LTQVQKTKDLLNNVA HHHHHHHHHHHHHHH | 54.11 | 21906983 | |
200 (in isoform 1) | Ubiquitination | - | 54.11 | 21906983 | |
208 | Phosphorylation | DLLNNVASDEANLEA HHHHHHHCCHHHHHH | 31.53 | 27499020 | |
216 (in isoform 1) | Ubiquitination | - | 41.86 | 21906983 | |
216 | Ubiquitination | DEANLEAKIEKRKLE CHHHHHHHHHHHHHH | 41.86 | 21906983 | |
254 | Ubiquitination | KTEEELQKQYDTYLE HCHHHHHHHHHHHHH | 64.55 | - | |
262 | Ubiquitination | QYDTYLEKFQNLTYL HHHHHHHHHHHHHHH | 50.05 | - | |
267 | Phosphorylation | LEKFQNLTYLEQQLE HHHHHHHHHHHHHHH | 33.34 | 29083192 | |
268 | Phosphorylation | EKFQNLTYLEQQLED HHHHHHHHHHHHHHH | 16.06 | 29083192 | |
297 | Ubiquitination | TLCLIQNKLKEEEKR HHHHHHHHCHHHHHH | 44.56 | - | |
308 | Phosphorylation | EEKRLLKSGSNDDSD HHHHHHHCCCCCCCC | 47.63 | 27732954 | |
310 | Phosphorylation | KRLLKSGSNDDSDID HHHHHCCCCCCCCCC | 44.15 | 27732954 | |
314 | Phosphorylation | KSGSNDDSDIDIQED HCCCCCCCCCCCCCC | 39.05 | 30278072 | |
324 | Phosphorylation | DIQEDDESDSELEER CCCCCCCCHHHHHHH | 54.13 | 30278072 | |
326 | Phosphorylation | QEDDESDSELEERRL CCCCCCHHHHHHHCC | 54.05 | 27732954 | |
392 | Phosphorylation | EDESISLSPTKPNRR CCCCCCCCCCCCCCC | 24.59 | 24719451 | |
403 | Phosphorylation | PNRRVRKSEPLDESD CCCCCCCCCCCCCCC | 33.60 | 23403867 | |
409 | Phosphorylation | KSEPLDESDNDF--- CCCCCCCCCCCC--- | 41.18 | 30278072 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CLUA1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CLUA1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CINP_HUMAN | CINP | physical | 16189514 | |
CLUS_HUMAN | CLU | physical | 15480429 | |
A4_HUMAN | APP | physical | 21832049 | |
EFC4B_HUMAN | CRACR2A | physical | 26186194 | |
UBX10_HUMAN | UBXN10 | physical | 26389662 | |
EFC4B_HUMAN | CRACR2A | physical | 28514442 | |
IFT20_HUMAN | IFT20 | physical | 27173435 | |
IFT57_HUMAN | IFT57 | physical | 27173435 | |
IF172_HUMAN | IFT172 | physical | 27173435 | |
ASAP2_HUMAN | ASAP2 | physical | 27173435 | |
STX18_HUMAN | STX18 | physical | 27173435 | |
PTHB1_HUMAN | BBS9 | physical | 27173435 | |
MIPT3_HUMAN | TRAF3IP1 | physical | 27173435 | |
BBS1_HUMAN | BBS1 | physical | 27173435 | |
TT30A_HUMAN | TTC30A | physical | 27173435 | |
BBS7_HUMAN | BBS7 | physical | 27173435 | |
BBS2_HUMAN | BBS2 | physical | 27173435 | |
TT30B_HUMAN | TTC30B | physical | 27173435 | |
ICK_HUMAN | ICK | physical | 27173435 | |
IFT46_HUMAN | IFT46 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-409, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-409, AND MASSSPECTROMETRY. |